Numerous clinical trials have established the role of cTnT in patients with suspected acute coronary syndrome for the diagnosis of acute myocardial infarction (AMI) as well as its power for risk strtification of patients with acute coronary syndromes (ACS) with [2] and without ST-segment elevation (STEMI/NSTEMI) [3]. Here, TNNT2 is linked to myocardial infarction.